Retatrutide — lab test, February 2026
Accumark Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 20 mg · Lab measured 21.12 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 5.3 mg using the measured mass, against 5 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | RT2002 |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | Accumark Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Accumark Labs on February 26, 2026. Reported purity: 100%. Net content: 21.12 mg against 20 mg labeled (106% of label). Batch RT2002. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion